Cochrane Abstracts
Non-steroidal antiandrogen monotherapy compared with luteinising hormone–releasing hormone agonists or surgical castration monotherapy for advanced prostate cancer: Cochrane systematic review
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Non-steroidal Antiandrogen Monotherapy Compared With Luteinising Hormone–releasing Hormone Agonists or Surgical Castration Monotherapy for Advanced Prostate Cancer: Cochrane Systematic Review." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/435285/all/Circuit_class_therapy_for_improving_mobility_after_stroke_Edited__no_change_to_conclusions_. Accessed 23 April 2024.
Non-steroidal antiandrogen monotherapy compared with luteinising hormone–releasing hormone agonists or surgical castration monotherapy for advanced prostate cancer: Cochrane systematic review. Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/435285/all/Circuit_class_therapy_for_improving_mobility_after_stroke_Edited__no_change_to_conclusions_. Accessed April 23, 2024.
Non-steroidal antiandrogen monotherapy compared with luteinising hormone–releasing hormone agonists or surgical castration monotherapy for advanced prostate cancer: Cochrane systematic review. In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/435285/all/Circuit_class_therapy_for_improving_mobility_after_stroke_Edited__no_change_to_conclusions_
Non-steroidal Antiandrogen Monotherapy Compared With Luteinising Hormone–releasing Hormone Agonists or Surgical Castration Monotherapy for Advanced Prostate Cancer: Cochrane Systematic Review [Internet]. In: Cochrane Abstracts. [cited 2024 April 23]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/435285/all/Circuit_class_therapy_for_improving_mobility_after_stroke_Edited__no_change_to_conclusions_.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Non-steroidal antiandrogen monotherapy compared with luteinising hormone–releasing hormone agonists or surgical castration monotherapy for advanced prostate cancer: Cochrane systematic review
ID - 435285
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/435285/all/Circuit_class_therapy_for_improving_mobility_after_stroke_Edited__no_change_to_conclusions_
DB - Evidence Central
DP - Unbound Medicine
ER -
